cysteamine has been researched along with Berger Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, L; Jin, J; Liu, P; Lu, WH; Lv, J; Xie, X; Zhang, H | 1 |
1 other study(ies) available for cysteamine and Berger Disease
| Article | Year |
|---|---|
Propensity of IgA to self-aggregate via tailpiece cysteine-471 and treatment of IgA nephropathy using cysteamine.
Topics: Animals; Cysteamine; Cysteine; Cystine Depleting Agents; Disease Models, Animal; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Immunoglobulin J-Chains; Kidney Glomerulus; Mice; Protein Aggregation, Pathological; Rats | 2021 |